He aha te tikanga o te "Maama"?
Karekau te kararehe e kawe i te huringa. E kore e whakawhanake i te mate a e kore e tukuna atu.
Acral Mutilation Syndrome (AMS) in dogs is a rare genetic disorder that affects certain breeds, leading to self-mutilation and severe pain. DNA testing for AMS is crucial for early diagnosis and prevention, helping pet owners understand their dog's genetic predisposition. By identifying carriers of the AMS gene, breeders can make informed decisions to reduce the incidence of this debilitating condition. Symptoms of AMS include excessive licking, biting, and injury to the paws and limbs. With the right genetic testing, owners can ensure better health outcomes for their pets. Don’t wait—consider a DNA test today to safeguard your dog's wellbeing. Discover peace of mind knowing you’re taking proactive steps for your furry friend!
Acral Mutilation Syndrome (AMS) is a rare genetic disorder observed in certain dog breeds, characterized by self-mutilating behaviors and severe pain in the paws. A DNA test for AMS can identify carriers of the gene responsible for this condition, allowing breeders to make informed decisions and reduce the risk of passing it on to future generations. Early diagnosis through genetic testing can lead to better management and treatment options for affected dogs. This test is particularly crucial for breeds known to be predisposed to AMS, ensuring the health and well-being of these animals. Responsible breeding practices can help prevent the emergence of this distressing syndrome in canine populations.
Kua whakauruhia tenei whakamatautau DNA mai i ta maatau kete Basic — he waahanga ano hoki o nga kete Basic, Standard, Advanced, Complete.
Tirohia nga Puka Whakamatau DNA →Acral Mutilation Syndrome (AMS) is a genetic condition that primarily affects certain dog breeds, leading to severe and often painful self-mutilation of the paws and limbs. This disorder is characterized by the loss of skin and tissue, which can result in significant discomfort and complications for affected dogs. AMS is a hereditary condition, and understanding its genetic basis is crucial for breeders and veterinarians alike in managing and preventing its occurrence.
DNA testing for Acral Mutilation Syndrome offers a reliable method for identifying carriers of the gene responsible for this condition. By analyzing specific genetic markers associated with AMS, veterinarians and breeders can make informed decisions about breeding practices. This proactive approach helps reduce the incidence of the syndrome in future generations and promotes the overall health of the population.
Dogs with Acral Mutilation Syndrome typically exhibit a range of clinical signs, including self-inflicted wounds on the paws and limbs. These wounds can lead to secondary infections, discomfort, and even behavioral changes due to pain and distress. Owners may notice that affected dogs exhibit compulsive licking or chewing at their limbs, which exacerbates the condition. In severe cases, the mutilation can result in significant tissue damage and require surgical intervention.
While there is no cure for Acral Mutilation Syndrome, effective management strategies can help alleviate the symptoms and improve the quality of life for affected dogs. Treatment may include pain management, wound care, and behavioral modification therapies to reduce the urge to self-mutilate. In some cases, veterinarians may recommend the use of protective devices, such as Elizabethan collars or paw wraps, to prevent further injury while the dog heals.
Genetic counseling plays a vital role in addressing Acral Mutilation Syndrome. Breeders should seek guidance from geneticists to understand the implications of producing offspring from affected or carrier animals. By utilizing DNA testing and adhering to responsible breeding practices, the risks associated with AMS can be significantly mitigated, ensuring healthier dogs and promoting ethical breeding standards.
Acral Mutilation Syndrome is a serious genetic condition that poses significant challenges for affected dogs and their owners. DNA testing serves as a crucial tool in identifying carriers and managing the condition effectively. Through a combination of early detection, responsible breeding, and comprehensive care, the impact of AMS can be minimized, leading to healthier lives for dogs and greater peace of mind for their caregivers.
Karekau te kararehe e kawe i te huringa. E kore e whakawhanake i te mate a e kore e tukuna atu.
Kao. He hauora te kararehe engari ka taea e ia te tuku i te huringa ki tona uri.
E rua nga kape whakarereke. Ko nga tohu haumanu kei te tumanakohia te mate. Kaua e whakatipuria.
Ko etahi o nga mate he hononga-a-ira, no reira ka rereke o raatau korero i runga i te ira kararehe.
This DNA test detects the mutation associated with Acral Mutilation Syndrome (AMS) in order to identify clear, carrier, or at-risk animals.
Ko te whakamatautau DNA ka awhina i nga kaiwhakawhanake ki te whakamahere i nga hononga haumaru ake me te whakaiti i te tupono ki te tuku i te huringa ki nga uri.
Ko te tikanga tuku iho mo tenei whakamatautau ko Autosomal Recessive.
This test analyses the mutation GDNF g.70875561C>T.
Ehara i te mea. Ko te whakamaoritanga ka whakawhirinaki ki te tauira tuku iho me te momo momo ira ka puta.
Plassais Jocelyn, Lagoutte Laetitia, Correard Solenne, Paradis Manon, Guaguère Eric, Hédan Benoit, Pommier Alix, Botherel Nadine, Cadiergues MarieChristine, Pilorge Philippe, Silversides David, Bizot Maud, Samuels Mark, Arnan Carme, Johnson Rory, Hitte Christophe, Salbert Gilles, Méreau Agnès, Quignon Pascale, Derrien Thomas, André Catherine. A Point Mutation in a lincRNA Upstream of GDNF Is Associated to a Canine Insensitivity to Pain: A Spontaneous Model for Human Sensory Neuropathies. PLoS Genet. 2016 Dec 29;12(12):e1006482. doi: 10.1371/journal.pgen.1006482. eCollection 2016 Dec.
To tūmataitinga, to whiringa
Ka whakamahi matou i nga pihikete whakahirahira hei whakahaere i te paetukutuku. Ko nga pihikete whiriwhiri (penei i nga kaiwhakarato ihirangi kua whakauruhia) kua monoa ma te taunoa ka whakahohea mena ka whakaae koe. Ka taea e koe te huri i to whiringa i nga wa katoa ma te whakamahi i te paatene "Pihikete".
E hiahiatia ana mo nga ahuatanga matua me te haumarutanga. Whakahohea i nga wa katoa.
Ka whakapai ake i nga ahuatanga penei i te penapena manakohanga, i nga taapiri kore-panui ranei.
Ka awhina tatou ki te mohio ki te whakamahinga o te waahi. Kua monoa e te taunoa.
Panuitanga / aroturuki puta noa i nga waahi (etahi riipene whakaata / mapi kua whakauruhia). Kua monoa e te taunoa.